Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_assertion type Assertion NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_head.
- NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_assertion wasGeneratedBy ECO_0000203 NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_provenance.
- NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_assertion wasDerivedFrom befree-20150227 NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_provenance.
- NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_assertion SIO_000772 19960344 NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_provenance.
- NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_assertion evidence source_evidence_literature NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_provenance.
- NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_assertion description "[The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381643.RAzVQEwjnNNNP9_q9yhyLmHtlqEtl_beHlKPavnWfBItk130_provenance.